These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20185808)

  • 1. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
    Mora S; Otvos JD; Rosenson RS; Pradhan A; Buring JE; Ridker PM
    Diabetes; 2010 May; 59(5):1153-60. PubMed ID: 20185808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
    Mora S; Otvos JD; Rifai N; Rosenson RS; Buring JE; Ridker PM
    Circulation; 2009 Feb; 119(7):931-9. PubMed ID: 19204302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
    Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
    Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
    Wojczynski MK; Glasser SP; Oberman A; Kabagambe EK; Hopkins PN; Tsai MY; Straka RJ; Ordovas JM; Arnett DK
    Lipids Health Dis; 2011 Oct; 10():181. PubMed ID: 22008512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
    Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
    Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.
    Sam S; Haffner S; Davidson MH; D'Agostino RB; Feinstein S; Kondos G; Perez A; Mazzone T
    Diabetes; 2008 Aug; 57(8):2022-7. PubMed ID: 18469202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis.
    Mackey RH; Mora S; Bertoni AG; Wassel CL; Carnethon MR; Sibley CT; Goff DC
    Diabetes Care; 2015 Apr; 38(4):628-36. PubMed ID: 25592196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Am J Cardiol; 2002 Oct; 90(8A):71i-76i. PubMed ID: 12419483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein subclass abnormalities and incident hypertension in initially healthy women.
    Paynter NP; Sesso HD; Conen D; Otvos JD; Mora S
    Clin Chem; 2011 Aug; 57(8):1178-87. PubMed ID: 21700954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Magnetic Resonance-Based Metabolomics and Risk of CKD.
    Geng TT; Chen JX; Lu Q; Wang PL; Xia PF; Zhu K; Li Y; Guo KQ; Yang K; Liao YF; Zhou YF; Liu G; Pan A
    Am J Kidney Dis; 2024 Jan; 83(1):9-17. PubMed ID: 37678743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR identifies atherogenic lipoprotein abnormalities in early diabetic nephropathy that are unrecognized by conventional analysis.
    Al-Shahrouri HZ; Ramirez P; Fanti P; Abboud H; Lorenzo C; Haffner S
    Clin Nephrol; 2010 Mar; 73(3):180-9. PubMed ID: 20178716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of lipoprotein subclasses with risk of all-cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
    Li R; Chen JX; Lu Q; Geng TT; Xia PF; Wang Y; Chen LK; Shan ZL; Pan A; Liu G
    Diabetes Obes Metab; 2023 Nov; 25(11):3259-3267. PubMed ID: 37492984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.